Trial Profile
Intracoronary administration of levosimendan in cardiac surgery patients [Sepelvaltimoihin annetun levosimendaanin vaikutuksia sydänleikkauspotilailla].
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary) ; Cobalamin
- Indications Left ventricular dysfunction
- Focus Therapeutic Use
- 11 Sep 2019 Status changed from suspended to discontinued.
- 27 Jun 2018 Planned End Date changed from 15 Jun 2018 to 15 Sep 2018.
- 19 Jun 2018 Planned End Date changed from 1 Dec 2014 to 15 Jun 2018.